XBIOTECH INC. Earnings Per Share, Basic and Diluted
XBIOTECH INC. (XBIT) reported Earnings Per Share, Basic and Diluted of -$0.21 per share for the 3-month period ending 2021-12-31, per its 10-K filed 2022-03-15.
Discontinued › Income Statement › Earnings Per Share
us-gaap:EarningsPerShareBasicAndDiluted · last filed 2022-03-15
- XBIOTECH INC. earnings per share, basic and diluted for the quarter ending 2021-12-31 was -$0.21.
- XBIOTECH INC. earnings per share, basic and diluted for the quarter ending 2021-09-30 was -$0.11.
- XBIOTECH INC. earnings per share, basic and diluted for the quarter ending 2021-06-30 was -$0.17.
- XBIOTECH INC. earnings per share, basic and diluted for the quarter ending 2021-03-31 was -$0.09.
- XBIOTECH INC. earnings per share, basic and diluted for fiscal 2018 was -$0.59.
- XBIOTECH INC. earnings per share, basic and diluted for fiscal 2017 was -$0.95.
- XBIOTECH INC. earnings per share, basic and diluted for fiscal 2016 was -$1.63.
- XBIOTECH INC. earnings per share, basic and diluted for fiscal 2015 was -$1.22.
| Period end | Earnings Per Share, Basic and Diluted 3 month | Earnings Per Share, Basic and Diluted 6 month | Earnings Per Share, Basic and Diluted 9 month | Earnings Per Share, Basic and Diluted 12 month |
|---|---|---|---|---|
| 2021-12-31 | -$0.21 10-K · filed 2022-03-15 | |||
| 2021-09-30 | -$0.11 10-K · filed 2022-03-15 | -$0.28 derived: net income ÷ weighted average shares · filed 2023-03-15 | -$0.37 10-Q · filed 2021-11-09 | |
| 2021-06-30 | -$0.17 10-K · filed 2022-03-15 | -$0.26 10-Q · filed 2021-08-09 | ||
| 2021-03-31 | -$0.09 10-K · filed 2022-03-15 | |||
| 2020-12-31 | -$0.06 10-K · filed 2022-03-15 | |||
| 2020-09-30 | -$0.09 10-K · filed 2022-03-15 | -$0.32 derived: net income ÷ weighted average shares · filed 2022-03-15 | -$0.30 10-Q · filed 2021-11-09 | |
| 2020-06-30 | -$0.24 10-K · filed 2022-03-15 | -$0.21 10-Q · filed 2021-08-09 | ||
| 2020-03-31 | $0.00 10-K · filed 2022-03-15 | |||
| 2019-09-30 | -$0.15 10-Q · filed 2020-11-09 | -$0.31 derived: net income ÷ weighted average shares · filed 2021-03-16 | -$0.47 10-Q · filed 2020-11-09 | -$0.64 derived: net income ÷ weighted average shares · filed 2021-03-16 |
| 2019-06-30 | -$0.16 10-Q · filed 2020-08-10 | -$0.32 10-Q · filed 2020-08-10 | -$0.49 derived: net income ÷ weighted average shares · filed 2021-03-16 | -$0.63 derived: net income ÷ weighted average shares · filed 2021-03-16 |
| 2019-03-31 | -$0.16 10-Q · filed 2020-05-11 | -$0.33 derived: net income ÷ weighted average shares · filed 2021-03-16 | -$0.47 derived: net income ÷ weighted average shares · filed 2021-03-16 | -$0.64 derived: net income ÷ weighted average shares · filed 2021-03-16 |
| 2018-12-31 | -$0.17 10-K · filed 2020-03-16 | -$0.31 derived: net income ÷ weighted average shares · filed 2020-03-16 | -$0.48 derived: net income ÷ weighted average shares · filed 2020-03-16 | -$0.59 10-K/A · filed 2019-03-15 |
| 2018-09-30 | -$0.14 10-K · filed 2020-03-16 | -$0.31 derived: net income ÷ weighted average shares · filed 2020-03-16 | -$0.42 10-Q · filed 2019-11-12 | -$0.64 derived: net income ÷ weighted average shares · filed 2020-03-16 |
| 2018-06-30 | -$0.16 10-K · filed 2020-03-16 | -$0.28 10-Q · filed 2019-08-09 | -$0.50 derived: net income ÷ weighted average shares · filed 2020-03-16 | -$0.67 derived: net income ÷ weighted average shares · filed 2020-03-16 |
| 2018-03-31 | -$0.11 10-K · filed 2020-03-16 | -$0.33 derived: net income ÷ weighted average shares · filed 2020-03-16 | -$0.51 derived: net income ÷ weighted average shares · filed 2020-03-16 | -$0.77 derived: net income ÷ weighted average shares · filed 2020-03-16 |
| 2017-12-31 | -$0.20 10-K/A · filed 2019-03-15 | -$0.40 derived: net income ÷ weighted average shares · filed 2019-03-15 | -$0.66 derived: net income ÷ weighted average shares · filed 2019-03-15 | -$0.95 10-K/A · filed 2019-03-15 |
| 2017-09-30 | -$0.18 10-K/A · filed 2019-03-15 | -$0.43 derived: net income ÷ weighted average shares · filed 2019-03-15 | -$0.72 10-Q · filed 2018-10-31 | -$1.24 derived: net income ÷ weighted average shares · filed 2019-03-15 |
| 2017-06-30 | -$0.26 10-K/A · filed 2019-03-15 | -$0.57 10-Q · filed 2018-08-09 | -$1.07 derived: net income ÷ weighted average shares · filed 2019-03-15 | -$1.45 derived: net income ÷ weighted average shares · filed 2019-03-15 |
| 2017-03-31 | -$0.32 10-K/A · filed 2019-03-15 | -$0.82 derived: net income ÷ weighted average shares · filed 2019-03-15 | -$1.20 derived: net income ÷ weighted average shares · filed 2019-03-15 | -$1.63 derived: net income ÷ weighted average shares · filed 2019-03-15 |
| 2016-12-31 | -$0.50 10-K · filed 2018-03-16 | -$0.89 derived: net income ÷ weighted average shares · filed 2019-03-15 | -$1.31 derived: net income ÷ weighted average shares · filed 2019-03-15 | -$1.63 10-K/A · filed 2019-03-15 |
| 2016-09-30 | -$0.38 10-K · filed 2018-03-16 | -$0.81 derived: net income ÷ weighted average shares · filed 2018-03-16 | -$1.12 10-Q · filed 2017-11-09 | -$1.49 derived: net income ÷ weighted average shares · filed 2018-03-16 |
| 2016-06-30 | -$0.42 10-K · filed 2018-03-16 | -$0.74 10-Q · filed 2017-08-08 | -$1.11 derived: net income ÷ weighted average shares · filed 2018-03-16 | -$1.44 derived: net income ÷ weighted average shares · filed 2018-03-16 |
| 2016-03-31 | -$0.32 10-K · filed 2018-03-16 | -$0.69 derived: net income ÷ weighted average shares · filed 2018-03-16 | -$1.02 derived: net income ÷ weighted average shares · filed 2018-03-16 | -$1.24 derived: net income ÷ weighted average shares · filed 2018-03-16 |
| 2015-12-31 | -$0.37 derived: net income ÷ weighted average shares · filed 2018-03-16 | -$0.70 derived: net income ÷ weighted average shares · filed 2018-03-16 | -$0.92 derived: net income ÷ weighted average shares · filed 2018-03-16 | -$1.22 10-K · filed 2018-03-16 |
| 2015-09-30 | -$0.33 10-Q · filed 2016-11-14 | -$0.55 derived: net income ÷ weighted average shares · filed 2016-11-14 | -$0.84 10-Q · filed 2016-11-14 | -$1.10 derived: net income ÷ weighted average shares · filed 2017-03-16 |
| 2015-06-30 | -$0.22 10-Q · filed 2016-08-12 | -$0.50 10-Q · filed 2016-08-12 | -$0.76 derived: net income ÷ weighted average shares · filed 2017-03-16 | -$1.04 derived: net income ÷ weighted average shares · filed 2017-03-16 |
| 2015-03-31 | -$0.29 10-Q · filed 2016-05-13 | -$0.55 derived: net income ÷ weighted average shares · filed 2017-03-16 | -$0.84 derived: net income ÷ weighted average shares · filed 2017-03-16 | -$1.01 derived: net income ÷ weighted average shares · filed 2017-03-16 |
| 2014-12-31 | -$0.25 derived: net income ÷ weighted average shares · filed 2017-03-16 | -$0.54 derived: net income ÷ weighted average shares · filed 2017-03-16 | -$0.71 derived: net income ÷ weighted average shares · filed 2017-03-16 | -$0.90 10-K · filed 2017-03-16 |
| 2014-09-30 | -$0.29 10-Q · filed 2015-11-13 | -$0.45 derived: net income ÷ weighted average shares · filed 2015-11-13 | -$0.64 10-Q · filed 2015-11-13 | |
| 2014-06-30 | -$0.16 10-Q · filed 2015-08-14 | -$0.35 10-Q · filed 2015-08-14 | ||
| 2014-03-31 | -$0.19 10-Q · filed 2015-06-18 | |||
| 2013-12-31 | -$0.45 10-K · filed 2016-04-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| HYPERION DEFI, INC. (HYPD) | United States | $0.065B | |
| Rein Therapeutics, Inc. (RNTX) | United States | $0.063B | -1.76 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Skye Bioscience, Inc. (SKYE) | United States | $0.061B | -0.48 |
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| TENAX THERAPEUTICS, INC. (TENX) | United States | $0.071B | -7.17 |
| CalciMedica, Inc. (CALC) | United States | $0.061B | -1.42 |
| TALPHERA, INC. (TLPH) | United States | $0.060B | |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |